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Abstract
Background—Cytosolic aldehyde dehydrogenase, or ALDH1A1, functions in ethanol 
detoxification, metabolism of neurotransmitters, and synthesis of retinoic acid. Because the 
promoter region of a gene can influence gene expression, the ALDH1A1 promoter regions were 
studied to identify polymorphism, to assess their functional significance, and to determine whether 
they were associated with a risk for developing alcoholism.
Methods—Sequence analysis was performed in the promoter region by using Asian, Caucasian, 
and African American subjects. The resulting polymorphisms were assessed for frequency in 
Asian, Caucasian, Jewish, and African American populations and tested for associations with 
alcohol dependence in Asian and African American populations of alcoholics and controls. The 
functional significance of each polymorphism was determined through in vitro expression analysis 
by using HeLa and HepG2 cells.
Results—Two polymorphisms, a 17 base pair (bp) deletion (−416/−432) and a 3 bp insertion 
(−524), were discovered in the ALDH1A1 promoter region: ALDH1A1*2 and ALDH1A1*3, 
respectively. ALDH1A1*2 was observed at frequencies of 0.035, 0.023, 0.023, and 0.012 in the 
Asian, Caucasian, Jewish, and African American populations, respectively. ALDH1A1*3 was 
observed only in the African American population, at a frequency of 0.029. By using HeLa and 
HepG2 cells for in vitro expression, the activity of the luciferase reporter gene was significantly 
decreased after transient transfection of ALDH1A1*3-luciferase compared with the wild-type 
construct ALDH1A1*1-luciferase. In an African American population, a trend for higher 
frequencies of the ALDH1A1*2 and ALDH1A1*3 alleles was observed in a population of 
alcoholics (p = 0.03 and f = 0.12, respectively) compared with the control population.
Conclusions—ALDH1A1*2 and ALDH1A1*3 may influence ALDH1A1 gene expression. Both 
ALDH1A1*2 and ALDH1A1*3 produce a trend in an African American population that may be 
indicative of an association with alcoholism; however, more samples are required to validate this 
observation. The underlying mechanisms contributing to these trends are still unknown.
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Human aldehyde dehydrogenase 1 (ALDH1A1) functions as an important enzyme in both 
the metabolism of acetaldehyde and the synthesis of retinoic acid (Elizondo et al., 2000; 
Ueshima et al., 1993). ALDH1A1 also has been implicated in several alcohol-related 
phenotypes, including alcoholism, alcohol-induced flushing, and alcohol sensitivity (Chan, 
1986; Yoshida, 1992). Studies suggest that low ALDH1A1 activity may contribute to 
alcohol sensitivity and alcohol-induced flushing in Caucasians and some Asians (Ward et 
al., 1994; Yoshida et al., 1989). Adverse reactions resulting from reduced ALDH1A1 
function may be influencing the predisposition for alcoholism in non-Asian populations 
(Eriksson, 2001). In fact, a study has identified a polymorphism in the coding region of 
ALDH1A1 that contributes to ethanol preference in high alcohol-preferring (HAP)/low 
alcohol-preferring (LAP) rats, suggesting that a functionally altered ALDH1A1 influences 
alcohol consumption in an animal model (Negoro et al., 1997; Nishiguchi et al., 2002). Due 
to its involvement in ethanol metabolism, ALDH1A1 is an interesting candidate for alcohol 
research.
Multiple aldehyde dehydrogenase isozymes have been characterized that exhibit similar 
functional properties implicated in ethanol detoxification, including ALDH1A1, ALDH1B1, 
ALDH2, and ALDH3A1 (Vasiliou and Pappa, 2000; Yoshida, 1992). The mitochondrial 
form of aldehyde dehydrogenase, or ALDH2, has been associated with a reduced incidence 
of alcoholism in certain Asian populations (Higuchi et al., 1995). In these populations, a 
functional polymorphism in ALDH2 leads to acetaldehyde accumulation, resulting in 
alcohol-induced flushing (Takeshita et al., 1994), but the underlying mechanism influencing 
alcoholic predisposition is still unknown (Li, 1997). The ALDH2 enzyme exhibits a higher 
affinity for acetaldehyde and primarily oxidizes acetaldehyde in humans (Klyosov et al., 
1996); however, the functions of the ALDH isozymes in the central nervous system remain 
unclear (Stewart et al., 1996; Tank et al., 1986).
The promoter region contains regulatory binding sites that are involved in gene expression 
and tissue specificity (Mitchell and Tjian, 1989). Mutations in regulatory binding sites can 
substantially affect gene regulation, altering enzyme levels that can ultimately contribute to 
phenotypic variability throughout a population. Polymorphism in the ALDH1A1 promoter 
region could affect the steady-state levels of ALDH1A1 and alter acetaldehyde and retinoid 
metabolism. Thus far, variants of the regulatory region in the promoter of the ALDH1A1 
gene have not yet been studied.
Although previous studies indicate that ALDH1A1 may contribute to alcoholism, alcohol 
sensitivity, and alcohol-induced flushing, no definitive evidence has been provided to 
adequately link ALDH1A1 to these phenotypes. The purpose of this study was to identify 
human ALDH1A1 promoter polymorphisms, to determine their functional significance, and 
to screen for associations between these polymorphisms and alcoholism.
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METHODS
Sequence Analysis
The ALDH1A1 promoter region was sequenced by using genomic DNA from 10 Caucasians, 
10 Asians, and 10 African Americans. On the basis of the human ALDH1A1 promoter 
sequence (accession number U28416), three primer pairs were designed: A1-forward (5′-
ATGCTGGAGCACTGGTTTCTT-3′) and A1-reverse (5′-
CAAAGCGGTGAGTAGGACAGG-3′), A2-forward (5′-
CAGGGTTCTCTCCTCACCAG-3′) and A2-reverse (5′-
GGCAGGAAGCCTTTGACTTT-3′), and A3-forward (5′-
TGGTGATTGTGTGTGACAGTG-3′) and A3-reverse (5′-
AGAATTTGAGGATTGAAAAGAGTC-3′). These primers were used to amplify three 
overlapping DNA fragments, extending from −690 to +100 with respect to the 
transcriptional start point (+1). The resulting polymerase chain reaction (PCR) products 
were purified (GenElute PCR Cleanup Kit, Sigma, St. Louis, MO) and sequenced (Thermo 
Sequenase Sequencing Kit, USB, Cleveland, OH).
Subjects
A general screen for frequency distribution of the ALDH1A1*1, ALDH1A1*2, and 
ALDH1A1*3 alleles was conducted by genotyping subjects in several populations, including 
Asian (n = 71), Caucasian (n = 239), African American (n = 85), and Jewish (n = 171). The 
Asian population consisted of Asian American men and women between the ages of 21 and 
26 years recruited from the University of California, San Diego (Luczak et al., 2002), and 
the African American population included men and women from San Diego county who 
were between 18 and 25 years old (Ehlers et al., 2003). Both the Asian American and 
African American populations were sampled from the general population. The Caucasian 
population was selected as a control population and contained both men and women 
recruited from the Helsinki affiliation of the State Alcohol Company; all subjects were 
excluded who displayed a previous history of alcoholism. The Jewish population consisted 
of men and women ranging in age from 18 to 82 years and were all of Eastern European 
descent (Carr et al., 2002).
To screen for associations between these polymorphisms and alcoholism, alcoholic and 
control populations were studied that included Hans (n = 70), Koreans (n = 83), Mongolians 
(n = 42), and African Americans (n = 116). In the Asian populations, all subjects were males 
between the ages of 18 and 70 years, without serious current physical disorders, and with no 
cross-ethnic marriages; alcohol dependence was classified according to International 
Classification of Diseases, 10th revision, diagnostic criteria (Shen et al., 1997). The African 
American population consisted of males and females who were acquired from Howard 
University in Washington, DC; these subjects were classified for alcohol dependence 
according to DSM-IV criteria. The DNA used for genotyping was obtained from the DNA 
bank maintained by the Molecular Biology Core of the Indiana University Alcohol Research 
Center, and Fisher’s exact test was used to calculate the significance of differences in allele 
frequencies between populations.
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Genotyping
Human genomic DNA was isolated from dried blood spots (Truett et al., 2000). The primers 
A4-forward (5′-GCACTGAAAATACACAAGACTGAT-3′) and A4-reverse (5′-
AGAATTTGAGGATTGAAAAGAGTC-3′) were designed on the basis of the human 
ALDH1A1 promoter sequence (accession number U28416) and used in PCR reactions to 
obtain [α-33P]deoxycytidine triphosphate-radiolabeled fragments. Products were 
electrophoresed on 6% acrylamide denaturing gels and scored on the basis of the mobility of 
each resulting PCR fragment.
Luciferase Reporter Constructs
DNA samples were selected from subjects testing positive for each allelic variant: 
ALDH1A1*1, ALDH1A1*2, and ALDH1A1*3. Two primers were designed – A5-forward 
(5′-ATTAGAGCTCCTGCTGGCTTTTCTGTTC-3′) and A5-reverse (5′-
CTTGAGATCTGGAACACAGGTGACTGGC-3′) – to encompass each polymorphism and 
contained flanking SstI and BglII restriction enzyme sites. Resulting PCR fragments were 
ligated into the pCR2.1-TOPO vector (Invitrogen, Carlsbad, CA) and sequenced to confirm 
that there were no errors. The plasmids were digested with SstI and BglII (Promega, 
Madison, WI). The resulting fragments were gel-isolated with the GenElute Agarose Spin 
Column (Sigma) and ligated to a linearized pGL-3-Basic vector upstream of the luciferase 
gene (Promega). Plasmids were isolated by using the EndoFree Plasmid Maxi Kit (Qiagen, 
Valencia, CA).
Transient Transfection and Luciferase Assays
Human liver HepG2 cells and human HeLa cells were cultured in Eagle’s minimal essential 
medium containing 7.5% NaHCO3, 2 mM Glutmax, 0.1 mM nonessential amino acids, 1 
mM pyruvate, and 10% fetal bovine serum (Invitrogen) and maintained at 37°C in a 
humidified 5% CO2 incubator. Twenty-four hours before transfection, 5.0 × 104 cells were 
plated into each well of a 24-well plate. Then 0.5 μg of each pGL-3 luciferase test plasmid 
was transfected per well by using Tfx 50 reagent (Promega). Cytomegalovirus (2.5 ng) 
Renilla vector was co-transfected with each pGL-3-luciferase test plasmid to serve as an 
internal control for transfection efficiency. The cells were incubated at 37°C for 24 hr, 
washed with phosphate-buffered saline, and then harvested by using passive lysis buffer 
(Promega). The cell extracts were assayed for firefly and Renilla luciferase activities in a 
TD-20/20 Luminometer by using the Dual-Luciferase Reporter Assay System according to 
the manufacturer’s instructions (Promega). Luciferase assays were performed three to six 
times in triplicate by using plasmids that were independently purified at least twice.
RESULTS
Polymorphism in the Human ALDH1A1 Promoter
Genomic DNA from Asians, Caucasians, and African Americans was sequenced to screen 
for polymorphisms in the ALDH1A1 promoter region. Two polymorphisms, ALDH1A1*2 
and ALDH1A1*3, were discovered in the promoter region of ALDH1A1: a 17 base pair (bp) 
deletion from position −416 to −432 relative to the transcriptional start site and a 3 bp 
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insertion at −524, respectively (Fig. 1). Because a 4 bp repeat exists on either side of the 
deletion, five possible sequences could be deleted that would result in the same ALDH1A1*2 
sequence (Fig. 2). There are three possible insertion sites (−524, −523, or −519) that would 
result in the same ALDH1A1*3 sequence (Fig. 2).
Frequency Distribution of ALDH1A1 Polymorphism in Various Ethnic Groups
Asian, Caucasian, African American, and Jewish populations were genotyped to determine 
the frequency of each polymorphism endemic in each population. An example of an 
autoradiogram depicting the three possible ALDH1A1 alleles is shown in Fig. 3. The 
frequency of the ALDH1A1*2 allele varied among ethnic groups, with frequencies of 0.035, 
0.023, 0.023, and 0.012 in the Asian, Caucasian, Jewish, and African American populations, 
respectively; ALDH1A1*3 was observed only in the African American population, at a 
frequency of 0.029 (Table 1).
Increased Frequency of ALDH1A1*2 and ALDH1A1*3 Alleles in a Population of African 
American Alcoholics
To establish whether the polymorphism was associated with the risk for developing 
alcoholism, alcoholic and control Asian and African American populations were genotyped. 
In an African American population recruited from the same region of the United States, a 
significant association was observed between the ALDH1A1*3 allele and the population of 
alcoholics compared with the control group (p = 0.03); a trend was also observed for the 
ALDH1A1*2 allele to be more frequent in the alcoholic group (p = 0.12; Table 2). In Asian 
populations, ALDH1A1*3 was not observed, and ALDH1A1*2 yielded no significant 
association with alcoholism when controlling for the ALDH2*2 genotype that was 
determined in a previous study (Table 2; Shen et al., 1997).
Reduced ALDH1A1*3 Promoter Activity In Vitro With HepG2 and HeLa Cells
To determine the functional effect each polymorphism might have on ALDH1A1 gene 
expression, PCR was used to generate DNA fragments containing the ALDH1A1*1, 
ALDH1A1*2, and ALDH1A1*3 alleles. These fragments were cloned into the pGL-3-Basic 
luciferase vector upstream of the luciferase promoter. All constructs were transiently 
transfected into HepG2 cells and HeLa cells, which constitutively express the endogenous 
ALDH1A1 gene (Schnier et al., 1999; Yanagawa et al., 1995). Luciferase expression was 
expressed in fold-change compared with the ALDH1A1*1-luciferase (luc) construct (Fig. 4). 
The ALDH1A1*3-luc construct exhibited a significant decrease in expression in both HeLa 
and HepG2 cells (0.43- and 0.22-fold decreases, respectively) compared with the 
ALDH1A1*1-luc construct (p < 0.05). The ALDH1A1*2-luc vector did not significantly alter 
luciferase activity in either HeLa or HepG2 cells.
DISCUSSION
In this study, two polymorphisms, ALDH1A1*2 and ALDH1A1*3, were discovered in the 
promoter region of human ALDH1A1. ALDH1A1*2, a 17-bp deletion, was identified in 
various populations, including Asians, Caucasians, and African Americans, whereas 
ALDH1A1*3, a 3-bp insertion, was observed only in African Americans. In both HeLa and 
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HepG2 cells, ALDH1A1*3 significantly decreased expression of the luciferase reporter gene 
in transient transfection assays (p < 0.05). In a population of African Americans, the 
ALDH1A1*3 allele yielded a significant association with alcoholism (p = 0.03), and a trend 
was also observed between subjects carrying the ALDH1A1*2 allele and alcoholism (p = 
0.12). However, unlike the ALDH2*2 allele, which is protective against alcoholism in 
Asians and is more prevalent in nonalcoholic subjects, the ALDH1A1*2 and ALDH1A1*3 
alleles were more frequent in the African American alcoholic population. In fact, none of the 
control subjects carried the ALDH1A1*2 or ALDH1A1*3 alleles (Table 2). These results 
suggest that expression of ALDH1A1 may be modulated by the ALDH1A1*2 and 
ALDH1A1*3 polymorphisms, contributing to alcohol-related effects by a mechanism 
different from that of ALDH2*2.
In reporter gene assays, the ALDH1A1*3 polymorphism significantly decreased expression 
of the luciferase gene; therefore, our data suggest that ALDH1A1*3 may be functional. A 
transcription factor database (Transcription Element Search System; http://
www.cbil.upenn.edu/tess/) was used to identify putative protein binding sites in the 
polymorphic regions of the ALDH1A1 promoter. The ALDH1A1*3 polymorphism (3-bp 
insertion) is located in close proximity to a predicted GATA binding site (Yanagawa et al., 
1995), and the ALDH1A1*2 polymorphism (17-bp deletion) eliminates a predicted c-myb 
binding site from the promoter region of ALDH1A1. Although in vitro expression analysis 
provides an indicator of the functional significance associated with regulatory 
polymorphisms, these assessments may not fully reflect the regulatory mechanisms 
underlying gene expression in vivo.
A reduction in ALDH1A1 expression could potentially influence the physiology of the 
central nervous system contributing to documented etiological symptoms of alcoholism. The 
ALDH1A1 gene is expressed in various tissues throughout the body, including the central 
nervous system (Stewart et al., 1996), and is known to be involved in two important 
biochemical functions: ethanol metabolism and cell differentiation. ALDH1A1 eliminates 
acetaldehyde, a potentially pharmacological and neurotoxic agent, from the nervous system 
(Brien and Loomis, 1983). ALDH1A1 has also been implicated in the synthesis of retinoic 
acid, an important agent in many developmental processes and an essential precursor in 
vitamin A production (Crabb et al., 2001). In fact, it has been suggested that acetaldehyde 
and retinaldehyde competition may be a contributing factor in vitamin A abnormalities 
observed in alcoholics (Ambroziak et al., 1999). In addition, ALDH1A1 has been linked to 
retinoid signaling in the central nervous system, a system integral to complex learned 
behavior (Denisenko-Nehrbass et al., 2000). In short, ALDH1A1*2 and ALDH1A1*3 may 
affect various systems of the body, as well as the central nervous system.
A variety of genes have been identified, by using genetic studies of association, that 
influence an individual’s susceptibility to alcoholism; the most prominent of these genes 
code for enzymes in the alcohol metabolism pathway (Li, 2000). In this study, both 
ALDH1A1*2 and ALDH1A1*3 were observed at higher frequencies in African American 
alcoholics when compared with an African American control population. These associations 
may reflect cause and effect relationships between these polymorphisms and an increased 
risk for alcoholism. However, due to the multifactorial nature of alcoholism and the ubiquity 
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and complexity of aldehyde dehydrogenase, it is difficult to postulate a mechanism 
underlying an association between ALDH1A1*2 and ALDH1A1*3 and alcohol-related 
phenotypes.
In conclusion, the promoter identified by the ALDH1A1*3 allele is significantly less active 
in transient transfection assays using both HepG2 and HeLa cells, and a tendency for an 
increase in ALDH1A1*2 and ALDH1A1*3 allele frequencies was observed in African 
American alcoholics. After controlling for the ALDH2*2 allele frequency, no association 
was evident between the ALDH1A1 polymorphisms and alcoholism in the Asian population. 
The underlying mechanisms associated with these polymorphisms are unknown; however, 
they seem to be different than that of the ALDH2*2 polymorphism observed in Asian 
populations. Thus, additional studies are needed to better understand the effects of these 
promoter polymorphisms on ALDH1A1 expression.
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Fig. 1. 
Sequence analysis of polymorphism in the human ALDH1A1 promoter region. (A) 
ALDH1A1*2: the box highlights the 17-bp sequence (−416/−432) that was deleted from 
ALDH1A1*1 to generate ALDH1A1*2. (B) ALDH1A1*3: the box designates the 3-bp 
insertion (−524). Arrows indicate common flanking nucleotides, and G, A, T, and C 
represent guanine, adenine, thiamine, and cytosine, respectively.
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Fig. 2. 
The human ALDH1A1 promoter region. Sequence analysis was performed on the region 
spanning −699 to +139 with respect to the transcriptional start point (+1). The magnified 
region extending from −586 to −372 designates the fragment that was amplified during the 
genotyping assay. Both polymorphisms are distinguished in this diagram: the 3-bp insertion 
(−524) and the 17-bp deletion (−416/−432). (A) The deletion of five possible fragments 
results in the same ALDH1A1*2 sequence due to flanking 5′-GGTC-3′ repeats. (B) Three 
possible insertions at −524, −523, or −519 generate the same ALDH1A1*3 sequence.
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Fig. 3. 
Autoradiogram of ALDH1A1*1, ALDH1A1*2, and ALDH1A1*3 genotypes. PCR was used 
to generate [α-33P]deoxycytidine triphosphate-radiolabeled fragments that were later 
separated on a 6% acrylamide gel by using electrophoresis. Each allele, ALDH1A1*1, 
ALDH1A1*2, and ALDH1A1*3, can be readily identified with this procedure. (A) A 
homozygous Caucasian with the genotype ALDH1A1*1/*1, the wild-type genotype. (B) A 
homozygous Asian with the genotype ALDHlA1*2/*2. (C) A heterozygous African 
American with the genotype ALDH1A1*1/*3.
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Fig. 4. 
Functional importance of ALDH1A1 promoter polymorphisms. Plasmids ALDH1A1*1, 
ALDH1A1*2, and ALDH1A1*3 were transfected into HepG2 and HeLa cells; luc+ denotes 
the luciferase gene. Each respective fragment amplified from the ALDH1A1 promoter 
extended from −659 to +39 with respect to the transcriptional start point, and the 
polymorphisms, the deletion (−416/−432) and the insertion (−524), are noted. The activity 
of each construct was normalized by co-transfection of the internal control plasmid, pRL-
CMV, and was expressed as fold change compared with the activity of ALDH1A1*1-luc. 
The mean ± SEM are representative of the results from three to six independent 
transfections performed in triplicate with two different plasmid preparations. The 
significance of the difference between mean values within and between multiple constructs 
was analyzed with ANOVA. ALDH1A1*3-luc significantly decreased luciferase expression 
in both Hep G2 and HeLa cells compared with ALDH1A1*1-luc (*p < 0.05). No significant 
change in expression was associated with ALDH1A1*2-luc.
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